Zebrafish transgenesis
One to two-cell stage embryos were microinjected through the chorion with single shots containing 50 pg of Tol2 transposase mRNA and 50 pg of purified ECR47-ZED vector, according to protocols published elsewhere (5) . Second generation (G2) Tg(ECR47-ZED:GFP) embryos were scanned for GFP expression 28 to 30 hours post-fertilization using a Zeiss LSM 501 META confocal laser microscope (Carl Zeiss Microscopy, Thornwood, NY).
We used G2 embryos to get more consistent results and avoid the phenotypic variation usually associated with transient transgenic assays in founder (G0) embryos (6) .
Zebrafish in situ hybridization
Dechorionated embryos were fixed in 1X PBS buffer containing 4% paraformaldehyde for 10 h at 4°C. The antisense digoxigenin-labeled adgrl3.1 RNA probe (from clone C1747IMAGp998F1911845Q corresponding to bases 4879 to 5597 of adgrl3.1, RefSeq:
XM_00517094) was prepared from linearized DNA template using a DIG RNA Labeling kit (Roche Diagnostics, Indianapolis, IN). Whole-mount in situ hybridization was performed according to Thisse and Thisse (7) . In situ hybridization patterns were scanned with a Leica MZ16 stereo-dissecting microscope (Leica Microsystems, Buffalo Grove, IL) and photographed using with a Zeiss Axiocam HRc camera (Carl Zeiss Microscopy).
siRNA-mediated mRNA knockdown
ON-TARGETplus SMARTpool human YY1 siRNA or non-targeting siRNA control (GE Dharmacon, Lafayette, CO) using the TransIT-TKO ® reagent (Mirus Bio). After 24 hours, supernatants were discarded and cells harvested with 1 mL of TRIzol ® reagent (Thermo Fisher Scientific).
YY1 expression knockdown was performed transiently using ON-TARGETplus SMARTpool human siRNA (GE Dharmacon, Lafayette, CO). Approximately 500 x 10 5 cells were seeded on Corning TM BioCoat TM poly-D-lysine 6-well plates and transfected with 25 nM siRNA the following day using the TransIT-TKO ® reagent (Mirus Bio). After 24 hours of transfection, cells were harvested with 1 mL of TRIzol ® reagent (Thermo Fisher Scientific) for total RNA isolation.
RNA extraction and gene expression analysis
Total RNA was isolated from TRIzol ® lysates using the PureLink ® RNA Mini kit (Thermo Fisher Scientific) and reverse-transcribed using the High-capacity cDNA Synthesis Kit (Thermo Fisher Scientific). ADGRL3 expression was determined by real-time quantitative PCR using pre-designed TaqMan® assays (Thermo Fisher Scientific) in a LightCycler ® 480 II instrument (Roche Diagnostics). Beta-actin was used as internal control for normalization of target gene expression. Relative mRNA expression was determined by the comparative C T (C T ) method (8) .
ADGRL3 cis-acting expression quantitative trail loci (cis-eQTL) analysis
Brain expression profiling of human post-mortem tissue was performed on Affymetrix GeneChip Human Exon 1.0 ST Arrays (Affymetrix, UK) (9). Brain tissues from 137 neuropathologically confirmed normal controls aged 16-102 years old were collected by the 9 UK Brain Expression Consortium (UKBEC) and made public under The Brain eQTL Almanac (http://www.braineac.org) (9) . ADHD risk SNP rs2271338 was investigated in this dataset for association with ADGRL3 expression levels in several brain regions. Other brain eQTL databases interrogated were SNPExpress (10), GTEx (11) , and GRASP (12) .
Transcription factor binding site prediction
The A B Figure S4 . Effect of YY1 downregulation on endogenous ADGRL3 mRNA expression.
(A) SH-SY5Y human neuroblastoma cells abundantly express ADGRL3 mRNA, but transcript levels are considerably much lower in U87 human glioblastoma. SH-SY5Y expression levels were set at 100% and U87 was expressed relative to it (1.8%). (B) YY1 siRNA knockdown for 24 h did not affect ADGRL3 expression in these two cell lines, suggesting that the ECR47-YY1 pair may not regulate ADGRL3 expression in differentiated cells.
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S5.
ADGRL3 mRNA expression in human post-mortem tissue is associated with the ADHD risk variant rs2271338. Data shown correspond to the three top ADGRL3 exon probe sets from Table  S7 . CRBL, cerebellar cortex; FCTX, frontal cortex; HIPP, hippocampus;
MEDU, medulla (specifically inferior olivary nucleus); OCTX, occipital cortex (specifically primary visual cortex); PUTM, putamen; SNIG, substantia nigra; TCTX, temporal cortex; THAL, thalamus; WHMT, intralobular white matter. Decreased ADGRL3 expression in the thalamus is significantly associated with the AA risk genotype (P < 0.001), as indicated by multiple probe sets in Table S7 .
Fetal
Infant Child Teen and adult Figure S6 . ADGRL3 expression in the prefrontal cortex across human lifespan. ADGRL3 expression peak occurs during fetal and infant development and comes to a more steady state in childhood, adolescence and adulthood. Differences in expression levels among individuals at a particular developmental stage may be due to the presence of polymorphisms acting as expression quantitative trait loci. This graph was taken from the Brain Cloud (http://braincloud.jhmi.edu) for ADGRL3 probe hHR005537. Expression levels (normalized log 2 (sample/reference)) are on the y axis, with age from gestation week 14 through 80 years old on the x axis. The linear age scale is variable within each of the individual stages of life. Data normalization and processing is described in (14) . . Chromosomal coordinates and sequences of 144 in vivo tested brain enhancers from the Vista Enhancer browser. Table S6 . Overrepresentation of predicted transcription factor binding sites in ECR47 and 144 in vivo tested brain enhancers.
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